Brandywine Global Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-164,259
| Closed | -$559K | – | 936 |
|
|
2018
Q3 | $559K | Buy |
164,259
+275
| +0.2% | +$936 | ﹤0.01% | 587 |
|
|
2018
Q2 | $617K | Sell |
163,984
-4,240
| -3% | -$16K | ﹤0.01% | 603 |
|
|
2018
Q1 | $689K | Buy |
+168,224
| New | +$689K | ﹤0.01% | 597 |
|
|
2016
Q3 | – | Sell |
-335,672
| Closed | -$2.22M | – | 1013 |
|
|
2016
Q2 | $2.22M | Sell |
335,672
-186,523
| -36% | -$1.24M | 0.02% | 544 |
|
|
2016
Q1 | $2.44M | Buy |
522,195
+31,775
| +6% | +$148K | 0.02% | 520 |
|
|
2015
Q4 | $2.48M | Buy |
490,420
+472,740
| +2,674% | +$2.39M | 0.02% | 532 |
|
|
2015
Q3 | $63K | Sell |
17,680
-2,798,154
| -99% | -$9.97M | ﹤0.01% | 833 |
|
|
2015
Q2 | $28.1M | Buy |
2,815,834
+894,435
| +47% | +$8.93M | 0.18% | 110 |
|
|
2015
Q1 | $24.5M | Buy |
+1,921,399
| New | +$24.5M | 0.16% | 131 |
|